3′-half of the thrombopoietin cDNA confers higher expression of erythropoietin at the RNA level but not at the protein level

Molecules and Cells

Volumn 19, Issue 2, 2005, Pages 198-204

  Kim, Tae Won ^a   Ji, Jin Woo ^a   Chang, Ho Gun ^a   Kim, Myoung Ok ^a   Ryoo, Zae Young ^b   Park, In Kook ^a   Kim, Sun Jung ^a  

^a Dongguk University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Erythropoietin; RNA and Protein Stability; Thrombopoietin; Untranslated Region

Indexed keywords

COMPLEMENTARY DNA; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; RNA; THROMBOPOIETIN; CASEIN; RECOMBINANT PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL TYPE; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STABILITY; TRANSGENIC ANIMAL; UNTRANSLATED REGION; 3' UNTRANSLATED REGION; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; KIDNEY; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; UDDER;

ANIMALIA;

3' UNTRANSLATED REGIONS; ANIMALS; CASEINS; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN, RECOMBINANT; HUMANS; KIDNEY; MAMMARY GLANDS, ANIMAL; MICE; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA STABILITY; THROMBOPOIETIN;

EID: 26044466752     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1016-8478(23)13156-6     Document Type: Article

References (28)

1. Aguirre, A., Castro-Palomino, N., De la Fuente, J., and Ovidio Castro, F. O. (1998) Expression of human erythropoietin transgenes and of the endogenous WAP gene in the mammary gland of transgenic rabbits during gestation and lactation. Transgenic Res. 7, 311-317.
2. Alexander, W. S. and Hyland, C. (2004) Thrombopoietin bioassay. Methods Mol. Biol. 272, 347-360.
3. Apostel, F., Dammann, R., Pfeifer, G. P., and Greeve, J. (2002) Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits. Biochim. Biophys. Acta 27, 384-394.
4. Bartley, T. D., Bogenberger, J., Hunt, P., Li, Y. S., Lu, H. S., et al. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77, 1117-1124.
5. de Sauvage, F. J., Hass, P. E., Spencer, S. D., Malloy, B. E., Gurney, A. L., et al. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369, 533-538.
6. Fisher, J. W. (2003) Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. 228, 1-14.
7. Foster, D. and Lok, S. (1996) Biological roles for the second domain of thrombopoietin. Stem Cells 1, 102-107.
8. Ghezzi, P. and Brines, M. (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 11, S37- 44.
9. Gurney, A. L., Kuang, W. J., Xie, M. H., Malloy, B. E., Eaton, D. L., et al. (1995) Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 85, 981-988.
10. Haas, M. J., Dragan, Y. P., Hikita, H., Shimel, R., Takimoto, K., et al. (1999) Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs. Am. J. Pathol. 155, 183-192.
11. Hoffman, R. C., Andersen, H., Walker, K., Krakover, J. D., Patel, S., et al. (1996) Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246. Biochemistry 35, 14849-14861.
12. Jacobs, K., Shoemaker, C., Rudersdorf, R., Neill, S. D., Kaufman, R. J., et al. (1985) Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313, 806-810.
13. Kim, T. W., Moon, H. B., and Kim, S. J. (2003) Interleukin-10 is up-regulated by prolactin and serum-starvation in cultured mammary epithelial cells. Mol. Cells 16, 168-172.
14. Kirito, K., Fox, N., and Kaushansky, K. (2004) Thrombopoietin induces HOXA9 nuclear transport in immature hematopoietic cells: potential mechanism by which the hormone favorably affects hematopoietic stem cells. Mol. Cell Biol. 24, 6751-6762.
15. Korhonen, V. P., Tolvanen, M., Hyttinen, J. M., Uusi-Oukari, M., Sinervirta, R., et al. (1997) Expression of bovine beta-lactoglobulin/human erythropoietin fusion protein in the milk of transgenic mice and rabbits. Eur. J. Biochem. 245, 482-489.
16. Linden, H. M. and Kaushansky, K. (2000) The glycan domain of thrombopoietin enhances its secretion. Biochemistry 39, 3044-3051.
17. Linden, H. M. and Kaushansky, K. (2002) The glycan domain of thrombopoietin (TPO) acts in trans to enhance secretion of the hormone and other cytokines. J. Biol. Chem. 277, 35240-35247.
18. Lok, S., Kaushansky, K., Holly, R. D., Kuijper, J. L., Lofton-Day, C. E., et al. (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369, 565-568.
19. Massoud, M., Attal, J., Thepot, D., Pointu, H., Stinnakre, M. G., et al. (1996) The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits. Reprod. Nutr. Dev. 36, 555-563.
20. Mikus, T., Maly, P., Poplstein, M., Landa, V., Trefil, P., et al. (2001) Expression of human erythropoietin gene in the mammary gland of a transgenic mouse. Folia Biol. 47, 187-195.
21. Narhi, L. O., Arakawa, T., Aoki, K. H., Elmore, R., Rohde, M. F., et al. (1991) The effect of carbohydrate on the structure and stability of erythropoietin. J. Biol. Chem. 266, 23022-23026.
22. Rodriguez, A., Castro, F. O., Aguilar, A., Ramos, B., Del Barco, D. G., et al. (1995) Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits. Biol. Res. 28, 141-153.
23. Sohn, B. H., Kim, S. J., Park, H., Park, S. K., Lee, S. C., et al. (1999) Expression and characterization of bioactive human thrombopoietin in the milk of transgenic mice. DNA Cell Biol. 18, 845-852.
24. Spivak, J. L. and Hogans, B. B. (1989) The in vivo metabolism of recombinant human erythropoietin in the rat. Blood 73, 90-99.
25. Takeuchi, M., Takasaki, S., Shimada, M., and Kobata, A. (1990) Role of sugar chains in the in vitro biological activity of human erythropoietin produced in recombinant Chinese hamster ovary cells. J. Biol. Chem. 265, 12127-12130.
26. Tibbles, H. E., Navara, C. S., Hupke, M. A., Vassilev, A. O., and Uckun, F. M. (2002) Thrombopoietin induces p-selectin expression on platelets and subsequent platelet/leukocyte interactions. Biochem. Biophys. Res. Commun. 292, 987-991.
27. Ulich, T. R., del Castillo, J., Senaldi, G., Cheung, E., Roskos, L., et al. (1999) The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice. Exp. Hematol. 27, 117-130.
28. Wagner, K. F., Katschinski, D. M., Hasegawa, J., Schumacher, D., Meller, B., et al. (2001) Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood 97, 536-542.